Skip to main content

 Related scientific articles (all)

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.

Authors : Morschhauser F, Fowler NH, Feugier P, Bouabdallah R, Tilly H, Palomba ML, Fruchart C, Libby EN, Casasnovas RO, Flinn IW, Haioun C, Maisonneuve H, Ysebaert L, Bartlett NL, Bouabdallah K, Brice P, Ribrag V, Daguindau N, Le Gouill S, Pica GM, Martin Garcia-Sancho A, López-Guillermo A, Larouche JF, Ando K, Gomes Da Silva M, André M, Zachée P, Sehn LH, Tobinai K, Cartron G, Liu D, Wang J, Xerri L, Salles GA, + collaborators (among others :, Bron D
Year : 2018
Journal : N Engl J Med
Volume : 379
Pages : 934-947

Mesenchymal stromal cells of the bone marrow and natural killer cells: cell interactions and cross modulation.

Authors : Najar M, Fayyad-Kazan M, Meuleman N, Bron D, Fayyad-Kazan H, Lagneaux L
Year : 2018
Journal : J Cell Commun Signal
Volume : 12(4)
Pages : 673-688

Insights into inflammatory priming of mesenchymal stromal cells: functional biological impacts.

Authors : Najar M, Krayem M, Merimi M, Burny A, Meuleman N, Bron D, Raicevic G, Lagneaux L
Year : 2018
Journal : Inflamm Res
Volume : 67(6)
Pages : 467-477

Immunohematology Mesenchymal Stromal Cell-based Therapy: From Research to Clinic.

Authors : Najar M, Krayem M, Meuleman N, Bron D, Hélène B, Lagneaux L
Year : 2018
Journal : Appl Immunohistochem Mol Morphol
Volume : 26(3)
Pages : e26-e43

Steps forward for cancer precision medicine.

Authors : Salgado R, Moore H, Martens JWM, Lively T, Malik S, McDermott U, Michiels S, Moscow JA, Tejpar S, McKee T, Lacombe D
Year : 2018
Journal : Nat Rev Drug Discov
Volume : 17(1)
Pages : 1-2

Immunomodulatory effects of foreskin mesenchymal stromal cells (FSK-MSCs) on natural killer (NK) cells.

Authors : Najar M, Fayyad-Kazan M, Meuleman N, Bron D, Fayyad-Kazan H, Lagneaux L
Year : 2018
Journal : J Cell Physiol
Volume : 233(7)
Pages : 5243-54

Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group o

Authors : Dieci MV, Radosevic-Robin N, Fineberg S, Van den Eynden G, Ternes N, Penault-Llorca F, Pruneri G, DAlfonso TM, Demaria S, Castaneda C, Sanchez J, Badve S, Michiels S, Bossuyt V, Rojo F, Singh B, Nielsen T, Viale G, Kim SR, Hewitt S, Wienert S, Loibl S, Rimm D, Symmans F, Denkert C, Adams S, Loi S, Salgado R
Year : 2018
Journal : Semin Cancer Biol
Volume : 52
Pages : 16-25

A gene signature to predict high tumour-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple negative breast cancer.

Authors : Criscitiello C, Bayar MA, Curigliano G, Symmans FW, Desmedt C, Bonnefoi H, Sinn B, Pruneri G, Vicier C, Pierga JY, Denkert C, Loibl S, Sotiriou C, Michiels S, André F
Year : 2018
Journal : Ann Oncol
Volume : 29(1)
Pages : 162-169

The Micronome of Mesenchymal Stromal Cells is partially responsive to Inflammation.

Authors : Fayyad-Kazan H, Fayyad-Kazan M, Merimi M, Meuleman N, Bron D, Lagneaux L, Najar M
Year : 2018
Journal : Cell Biol Int
Volume : 42(2)
Pages : 254-260

White blood cell counts in a geriatric hospitalized population: A poor diagnostic marker of infection.

Authors : Compté N, Dumont L, Bron D, De Breucker S, Praet JP, Bautmans I, Pepersack T
Year : 2018
Journal : Exp Gerontol
Volume : 114
Pages : 87-92

Monoclonal gammopathy of undetermined significance : when and why to look for them ?

Authors : Meuleman N, Vercruyssen M
Year : 2018
Journal : Rev Med Brux
Volume : 39
Pages : 302-306

Malignant or benign hyperleukocytosis ?

Authors : Spilleboudt C, Thibaut P, Varlet E, Bron D
Year : 2018
Journal : Rev Med Brux
Volume : 39
Pages : 291-295

Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma.

Authors : Perrot A, Lauwers-Cances V, Corre J, Robillard N, Hulin C, Chretien ML, Dejoie T, Maheo S, Stoppa AM, Pegourie B, Karlin L, Garderet L, Arnulf B, Doyen C, Meuleman N, Royer B, Eveillard JR, Benboubker L, Dib M, Decaux O, Jaccard A, Belhadj K, Brechignac S, Kolb B, Fohrer C, Mohty M, Macro M, Richardson PG, Carlton V, Moorhead M, Willis T, Faham M, Anderson KC, Harousseau JL, Leleu X, Facon T, Moreau P, Attal M, Avet-Loiseau H, Munshi N
Year : 2018
Journal : Blood
Volume : 132
Pages : 2456-2464

Weight loss, fever and arthralgia in a 43-year-old man treated for follicular lymphoma.

Authors : Vandeputte M, Couturier B, Vandergheynst F, Maerevoet M, Jullie ML, Kolivras A, Fontanges Q, Verset L, André J, Cogan E, Boysson H
Year : 2017
Journal : Rev Med Interne
Volume : 38(9)
Pages : 633-637

Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma.

Authors : Dreyling M, Morschhauser F, Bouabdallah K, Bron D, Cunningham D, Assouline SE, Verhoef G, Linton K, Thieblemont C, Vitolo U, Hiemeyer F, Giurescu M, Garcia-Vargas J, Gorbatchevsky I, Liu L, Koechert K, Peña C, Neves M, Childs BH, Zinzani PL
Year : 2017
Journal : Ann Oncol
Volume : 28(9)
Pages : 2169-2178

Viral-induced Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplant.

Authors : Dosin G, Aoun F, El Rassy E, Assi T, Lewalle P, Blanc J, Van Velthoven R, Bron D
Year : 2017
Journal : Clin Lymphoma Myeloma Leuk
Volume : 17(7)
Pages : 438-442

Comparison and immunobiological characterization of retinoic acid inducible gene-I-like receptor expression in mesenchymal stromal cells.

Authors : Raicevic G, Najar M, Busser H, Crompot E, Bron D, Toungouz M, Lagneaux L
Year : 2017
Journal : Sci Rep
Volume : 7(1)
Pages : 2896

Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B-cells from apoptosis, enhance their migration and induce gene expression modifications.

Authors : Crompot E, Van Damme M, Pieters K, Vermeersch M, Perez-Morga D, Mineur P, Maerevoet M, Meuleman N, Bron D, Lagneaux L, Stamatopoulos B
Year : 2017
Journal : Haematologica
Volume : 102(9)
Pages : 1594-1604

Intraocular T-cell Lymphoma: Clinical Presentation, Diagnosis, Treatment, and Outcome.

Authors : Chaput F, Amer R, Baglivo E, Touitou V, Kozyreff A, Bron D, Bodaghi B, LeHoang P, Bergstrom C, Grossniklaus HE, Chan CC, Peer J, Caspers LE
Year : 2017
Journal : Ocul Immunol Inflamm
Volume : 25(5)
Pages : 639-648

Unmet needs in the scientific approach to older patients with lymphoma.

Authors : Bron D, Aurer I, André MPE, Bonnet C, Caballero D, Falandry C, Kimby E, Soubeyran P, Zucca E, Bosly A, Coiffier B
Year : 2017
Journal : Haematologica
Volume : 102
Pages : 972-975